"Cephamycins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.
| Descriptor ID |
D002513
|
| MeSH Number(s) |
D02.065.589.099.249.250 D02.886.665.074.250 D03.633.100.300.249.250
|
| Concept/Terms |
Cephamycins- Cephamycins
- Antibiotics, Cephamycin
- Cephamycin Antibiotics
|
Below are MeSH descriptors whose meaning is more general than "Cephamycins".
Below are MeSH descriptors whose meaning is more specific than "Cephamycins".
This graph shows the total number of publications written about "Cephamycins" by people in this website by year, and whether "Cephamycins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cephamycins" by people in Profiles.
-
Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, Sondheimer SJ, Hendrix SL, Amortegui A, Trucco G, Songer T, Lave JR, Hillier SL, Bass DC, Kelsey SF. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002 May; 186(5):929-37.
-
White RL, Kays MB, Friedrich LV, Del Bene VE. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins. J Antimicrob Chemother. 1993 Jan; 31(1):57-64.
-
Kays MB, White RL, Friedrich LV, Del Bene VE. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties. Clin Ther. 1991 Sep-Oct; 13(5):596-605.
-
Stanfield JA, DiPiro JT. Interference of cefmetazole sodium and cefotetan disodium with urine-glucose testing systems. Am J Hosp Pharm. 1988 Mar; 45(3):625-6.
-
Del Bene VE, Carek PJ, Twitty JA, Burkey LJ. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance. Antimicrob Agents Chemother. 1985 May; 27(5):817-20.
-
Rambo WM, Del Bene VE, Burkey LG, Collins CD, Richmond DK. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections. Rev Infect Dis. 1982 Nov-Dec; 4 Suppl:S683-7.
-
Brown JE, Del Bene VE, Collins CD. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother. 1981 Feb; 19(2):248-52.